Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

10x Genomics (TXG) Interest Expenses (2018 - 2025)

10x Genomics (TXG) has disclosed Interest Expenses for 8 consecutive years, with -$3000.0 as the latest value for Q3 2025.

  • Quarterly Interest Expenses fell 250.0% to -$3000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $5000.0 through Jun 2025, down 54.55% year-over-year, with the annual reading at $4000.0 for FY2024, 87.88% down from the prior year.
  • Interest Expenses hit -$3000.0 in Q3 2025 for 10x Genomics, down from $3000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $221000.0 in Q1 2021 to a low of -$3000.0 in Q3 2025.
  • Historically, Interest Expenses has averaged $81117.6 across 5 years, with a median of $19000.0 in 2023.
  • Biggest YoY gain for Interest Expenses was 200.0% in 2025; the steepest drop was 250.0% in 2025.
  • Year by year, Interest Expenses stood at $217000.0 in 2021, then tumbled by 42.4% to $125000.0 in 2022, then plummeted by 93.6% to $8000.0 in 2023, then plummeted by 75.0% to $2000.0 in 2024, then crashed by 250.0% to -$3000.0 in 2025.
  • Business Quant data shows Interest Expenses for TXG at -$3000.0 in Q3 2025, $3000.0 in Q2 2025, and $2000.0 in Q3 2024.